Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Cancer play Syndax pulls IPO

    Syndax Pharmaceuticals Inc. (Waltham, Mass.) withdrew its IPO on NASDAQ. The company did not give a reason in a regulatory filing, and declined comment to BioCentury. Planned underwriters were Deutsche Bank; Jefferies; …

    Published on 1/23/2015
  • FINANCIAL NEWS: Egalet's rise continues after abuse-deterrence data

    Egalet Corp. (NASDAQ:EGLT) rose $2.43 (40%) to $8.54 on Friday, a day after reporting that 60 mg Egalet-001 had significantly lower abuse potential compared to a marketed morphine tablet. Egalet posted two-day gains of…

    Published on 1/23/2015
  • FINANCIAL NEWS: Funding roundup: Auspex, Radius, Zafgen, Otonomy, Verastem, Vitae

    Auspex Pharmaceuticals Inc. (NASDAQ:ASPX), Radius Health Inc. (NASDAQ:RDUS), Zafgen Inc. (NASDAQ:ZFGN), Otonomy Inc. (NASDAQ:OTIC), Verastem Inc. (NASDAQ:VSTM) and Vitae Pharmaceuticals Inc. (NASDAQ:VTAE) have raised …

    Published on 1/23/2015
  • FINANCIAL NEWS: Gene therapy newco Genenta raises EUR 6.2M toward series A

    Gene therapy newco Genenta Science s.r.l. (Milan, Italy) raised EUR 6.2 million ($7.2 million) in a series A round from undisclosed private investors including individuals, entrepreneurs, managers and family offices. …

    Published on 1/23/2015
  • FINANCIAL NEWS: Venture tracks

    Frazier Healthcare promoted Ben Magnano to general partner from senior associate. He is a member of Frazier's growth buyout team, which invests in healthcare services, pharmaceutical services, healthcare IT, products, …

    Published on 1/23/2015
  • FINANCIAL NEWS: CAR T newco Autolus debuts with L30M series A

    Immunotherapy company Autolus Ltd. (London, U.K.) closed a L30 million ($45.5 million) series A round from Syncona Partners. The University College London spinout is developing chimeric antigen receptor (CAR) T cell …

    Published on 1/22/2015
  • FINANCIAL NEWS: Funding roundup: BioMarin, Puma, Intrexon

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Puma Biotechnology Inc. (NYSE:PBYI) and Intrexon Corp. (NYSE:XON) raised more than $1 billion in follow-on offerings on Thursday.In the day's largest offering, BioMarin raised…

    Published on 1/22/2015
  • FINANCIAL NEWS: Gilde closes EUR 100M healthcare services fund

    Gilde Healthcare closed its second healthcare services fund at EUR 100 million ($115.8 million). The firm will invest Gilde Healthcare Services II in lower mid-market companies with EUR 7.5 million-EUR 75 million ($8.7…

    Published on 1/22/2015
  • FINANCIAL NEWS: Funding roundup: Alnylam, Keryx, Versartis, Arena, Agile

    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Versartis Inc. (NASDAQ:VSAR), Arena Pharmaceuticals Inc. (NASDAQ:ARNA) and Agile Therapeutics Inc. (NASDAQ:AGRX) raised north of $…

    Published on 1/21/2015
  • FINANCIAL NEWS: Gene therapy play RegenxBio raises $30M

    RegenxBio Inc. (Washington, D.C.) raised $30 million in an untranched series C round led by new investors Venrock and Brookside Capital. New investor Deerfield Management, an undisclosed new investor and existing …

    Published on 1/21/2015
  • FINANCIAL NEWS: Alnylam, Keryx propose follow-ons

    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) each revealed plans for follow-on offerings on Tuesday.Alnylam proposed to raise $450 million in a follow-on underwritten by …

    Published on 1/20/2015
  • FINANCIAL NEWS: CAR T plays rebound after Thursday slide

    Kite Pharma Inc. (NASDAQ:KITE) and other developers of chimeric antigen receptor (CAR) T cell therapies recovered some of their losses Friday after dipping sharply Thursday on a report suggesting Kite may price its …

    Published on 1/16/2015
  • FINANCIAL NEWS: Swiss stocks still tumbling on currency move

    Swiss stocks continued to fall Friday after the Swiss National Bank decided Thursday to abandon the minimum exchange rate of CHF1.20 per euro.Since Wednesday's close, Actelion Ltd. (SIX:ATLN) has lost CHF23.80 (19%) to …

    Published on 1/16/2015
  • FINANCIAL NEWS: Venture tracks

    New Enterprise Associates promoted Frank Torti to partner from principal. Torti joined NEA in 2007 and is a director at NeoTract Inc. (Pleasanton, Calif.), Galera Therapeutics Inc. (Malvern, Pa.) and Cerecor Inc. (…

    Published on 1/16/2015
  • FINANCIAL NEWS: CTI raises C$134M toward second fund

    Canadian venture firm CTI Life Sciences raised C$134 million ($112.9 million) in the first close of its second fund, CTI II. The firm aims to close the fund with a total of C$175 million ($147.4 million) by November.New…

    Published on 1/15/2015
  • FINANCIAL NEWS: NEA sets $2.5B target for upcoming fund

    New Enterprise Associates proposed in a regulatory filing a $2.5 billion target for New Enterprise Associates 15, a new venture fund. The firm, which declined to discuss the filing, traditionally invests across all …

    Published on 1/14/2015
  • FINANCIAL NEWS: Migraine play CoLucid raises $37.1M

    CoLucid Pharmaceuticals Inc. (Durham, N.C.) raised $37.1 million in a series C round led by TVM Capital Life Science. New investors included Novo Ventures and Auriga Partners. Existing investors Pappas Ventures; Domain …

    Published on 1/13/2015
  • FINANCIAL NEWS: Personalis raises $33M series C round

    Personalis Inc. (Menlo Park, Calif.) raised $33 million in series C round led by existing investor Lightspeed Venture Partners. Personalis said all its series A round investors also participated, including Abingworth …

    Published on 1/13/2015
  • FINANCIAL NEWS: 10X Genomics raises $55.5M series B

    10X Genomics (Pleasanton, Calif.) raised $55.5 million in an untranched series B round. Existing investor Foresite Capital led the round. Venrock, which led the company's $22.4 million series A round, also participated,…

    Published on 1/12/2015
  • FINANCIAL NEWS: CAR play Cellectis plans listing in U.S.

    Cellectis S.A. (Euronext:ALCLS) on Thursday said it plans to list on a U.S. exchange, but has not yet decided on the date, size or terms of the public offering. The immunotherapy play gained EUR 2.90 (15%) to EUR 22 on …

    Published on 1/9/2015
  • FINANCIAL NEWS: Financial tracks

    H.C. Wainwright hired Ching-Yi Lin as a managing director in equity research and senior biotechnology analyst. She was a senior research associate at Stifel covering the pharmaceutical sector. Sofinnova Ventures hired …

    Published on 1/9/2015
  • FINANCIAL NEWS: PureTech raises another $50M

    PureTech Ventures (Boston, Mass.) raised $50 million from Invesco Perpetual and other existing investors. The firm raised $57 million in October 2014 in a separate round that included Invesco.The science and technology …

    Published on 1/9/2015
  • FINANCIAL NEWS: China's Hua Medicine raises $25M Series B

    Hua Medicine Ltd. (Shanghai, China) raised $25 million in a series B round led by Ally Bridge Group. New investors included Frontline BioVentures and TF Capital. Existing investors Arch Venture Partners; Venrock; …

    Published on 1/8/2015
  • FINANCIAL NEWS: Funding roundup: Alder, Avalanche, OvaScience, Stemline

    Four biotechs -- Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Avalanche Biotechnologies Inc. (NASDAQ:AAVL), OvaScience Inc. (NASDAQ:OVAS) and Stemline Therapeutics Inc. (NASDAQ:STML) -- raised a total of $470.5 million …

    Published on 1/8/2015
  • FINANCIAL NEWS: Strategics join $35M A round for Surface Oncology

    Cancer immunotherapy play Surface Oncology Inc. (Cambridge, Mass.) raised $35 million in a series A round led by existing investor Atlas Venture. New investors Fidelity Biosciences; Lilly Ventures; New Enterprise …

    Published on 1/8/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993